NCDB Analysis of Melanoma 2004–2015: Epidemiology and Outcomes by Subtype, Sociodemographic Factors Impacting Clinical Presentation, and Real-World Survival Benefit of Immunotherapy Approval

SIMPLE SUMMARY: Melanoma is clinicopathologically a heterogeneous disease with rising incidence. Metastatic disease is associated with poor outcomes, and immunotherapy was first approved in 2011 for its treatment. In our analysis of a large national database, we describe the epidemiology, clinical p...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Sunny R. K., Malapati, Sindhu J., Kumar, Rohit, Willner, Christopher, Wang, Ding
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004999/
https://www.ncbi.nlm.nih.gov/pubmed/33810182
http://dx.doi.org/10.3390/cancers13061455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004999/
https://www.ncbi.nlm.nih.gov/pubmed/33810182
http://dx.doi.org/10.3390/cancers13061455

Ejemplares similares